Litcius/Paper detail

p53-R273H promotes cancer cell migration via upregulation of neuraminidase-1

Tao� Lv, Hong Lv, Junjie Fei, Yajun Xie, Daqing Lian, Jiang Hu, Lizhou Tang, Xiaodong Shi, Jianling Wang, Shibo Zhang, Fengtian Li, Xianjie Jiang, Yong Yi

2020Journal of Cancer22 citationsDOIOpen Access PDF

Abstract

Accumulating evidence indicates that hotspot p53 mutants have gain-of-function in promoting cell migration and tumor metastasis. However, the molecular mechanisms are not completely understood. Here, we show that a hotspot mutation, p53-R273H, promotes non-small cell lung cancer (NSCLC) cell migration and upregulates the mRNA and protein expression of neuraminidase-1 (NEU1), a sialidase involved in cell proliferation, cell migration and tumorigenesis. Silencing of NEU1 leads to upregulation of integrin β4 which significantly inhibits NSCLC cell migration induced by p53-R273H. Mechanistically, p53-R273H promotes NEU1 transcription via activation of AKT signaling. Importantly, NEU1 expression is upregulated in human NSCLC samples harboring mutant p53 and is associated with poor clinical outcome. Overall, this study highlights an important role of NEU1 in p53-R273H-induced NSCLC cell migration and provides a potential target for NSCLC diagnosis and treatment.

Topics & Concepts

Downregulation and upregulationCell migrationCancer researchGene silencingCarcinogenesisProtein kinase BCellCell growthBiologyCell biologySignal transductionCancerGeneGeneticsGlycosylation and Glycoproteins ResearchCancer Research and TreatmentsUbiquitin and proteasome pathways
p53-R273H promotes cancer cell migration via upregulation of neuraminidase-1 | Litcius